GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
13.69
+0.19 (1.41%)
Sep 14, 2026, 3:00 PM CST
SHA:600771 Revenue
GuangYuYuan Chinese Herbal Medicine had revenue of 336.12M CNY in the quarter ending June 30, 2026, a decrease of -7.19%. This brings the company's revenue in the last twelve months to 1.41B, up 5.46% year-over-year. In the year 2025, GuangYuYuan Chinese Herbal Medicine had annual revenue of 1.37B with 12.11% growth.
Revenue (ttm)
1.41B
Revenue Growth
+5.46%
P/S Ratio
4.67
Revenue / Employee
810.99K
Employees
1,744
Market Cap
6.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37B | 147.88M | 12.11% |
| Dec 31, 2024 | 1.22B | -62.59M | -4.87% |
| Dec 31, 2023 | 1.28B | 153.30M | 13.56% |
| Dec 31, 2022 | 1.13B | 276.50M | 32.37% |
| Dec 31, 2021 | 854.22M | -255.21M | -23.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.82B |
| Zhejiang Int'l Group | 34.20B |
| Yifan Pharmaceutical | 4.97B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.21B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.84B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Hangzhou Minsheng Healthcare | 854.51M |
| Chongqing Lummy Pharmaceutical | 748.94M |